Hawes, B M*
Dotaz
Zobrazit nápovědu
... Khokhlova • -- Michael B. ... ... Murad • Mark Topazian -- 5 New Techniques in EUS: Real-Time Elastography, Contrast-Enhanced EUS, and ... ... EUS in the Esophagus and Mediastinum 61 -- Robert H. ... ... Annema -- 8 EUS in Esophageal Cancer 83 Mohamad A. ... ... Fujii • Michael J. ...
3rd ed. xvi, 395 s. : il., tab. ; 29 cm
Atypical teratoid/rhabdoid tumor (ATRT) is an aggressive central nervous system tumor characterized by loss of SMARCB1/INI1 protein expression and comprises three distinct molecular groups, ATRT-TYR, ATRT-MYC and ATRT-SHH. ATRT-SHH represents the largest molecular group and is heterogeneous with regard to age, tumor location and epigenetic profile. We, therefore, aimed to investigate if heterogeneity within ATRT-SHH might also have biological and clinical importance. Consensus clustering of DNA methylation profiles and confirmatory t-SNE analysis of 65 ATRT-SHH yielded three robust molecular subgroups, i.e., SHH-1A, SHH-1B and SHH-2. These subgroups differed by median age of onset (SHH-1A: 18 months, SHH-1B: 107 months, SHH-2: 13 months) and tumor location (SHH-1A: 88% supratentorial; SHH-1B: 85% supratentorial; SHH-2: 93% infratentorial, often extending to the pineal region). Subgroups showed comparable SMARCB1 mutational profiles, but pathogenic/likely pathogenic SMARCB1 germline variants were over-represented in SHH-2 (63%) as compared to SHH-1A (20%) and SHH-1B (0%). Protein expression of proneural marker ASCL1 (enriched in SHH-1B) and glial markers OLIG2 and GFAP (absent in SHH-2) as well as global mRNA expression patterns differed, but all subgroups were characterized by overexpression of SHH as well as Notch pathway members. In a Drosophila model, knockdown of Snr1 (the fly homologue of SMARCB1) in hedgehog activated cells not only altered hedgehog signaling, but also caused aberrant Notch signaling and formation of tumor-like structures. Finally, on survival analysis, molecular subgroup and age of onset (but not ASCL1 staining status) were independently associated with overall survival, older patients (> 3 years) harboring SHH-1B experiencing relatively favorable outcome. In conclusion, ATRT-SHH comprises three subgroups characterized by SHH and Notch pathway activation, but divergent molecular and clinical features. Our data suggest that molecular subgrouping of ATRT-SHH has prognostic relevance and might aid to stratify patients within future clinical trials.
- MeSH
- gen SMARCB1 genetika metabolismus MeSH
- lidé MeSH
- metylace DNA MeSH
- nádory centrálního nervového systému * genetika MeSH
- neuroepitelové nádory * genetika MeSH
- prognóza MeSH
- proteiny hedgehog genetika metabolismus MeSH
- rhabdoidní nádor * genetika MeSH
- teratom * genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The present article describes two unrelated cases of progressive myoclonic epilepsy (PME) of the Lafora's disease and Unverricht-Lundborg types who were treated with topiramate (TPM) as add-on therapy for their myoclonus. After the initiation of topiramate therapy both cases responded with marked decrease in myoclonic seizure frequency and improvement of quality of life. Topiramate appears to be a useful alternative agent in cases of PME and could be consider for adjunctive therapy.
- MeSH
- antikonvulziva terapeutické užití MeSH
- fruktosa analogy a deriváty terapeutické užití MeSH
- kombinovaná farmakoterapie MeSH
- lidé MeSH
- mladý dospělý MeSH
- myoklonické epilepsie progresivní farmakoterapie MeSH
- Check Tag
- lidé MeSH
- mladý dospělý MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
BACKGROUND: The progressive myoclonic epilepsies (PME) are a heterogeneous group of disorders in which a specific diagnosis cannot be made in a subset of patients, despite exhaustive investigation. C9orf72 repeat expansions are emerging as an important causal factor in several adult-onset neurodegenerative disorders, in particular frontotemporal lobar degeneration and amyotrophic lateral sclerosis. An association with PME has not been reported previously. OBJECTIVE: To identify the causative mutation in a Belgian family where the proband had genetically unexplained PME. RESULTS: We report a 33-year old woman who had epilepsy since the age of 15 and then developed progressive cognitive deterioration and multifocal myoclonus at the age of 18. The family history suggested autosomal dominant inheritance of psychiatric disorders, epilepsy, and dementia. Thorough workup for PME including whole exome sequencing did not reveal an underlying cause, but a C9orf72 repeat expansion was found in our patient and affected relatives. Brain biopsy confirmed the presence of characteristic p62-positive neuronal cytoplasmic inclusions. CONCLUSION: C9orf72 mutation analysis should be considered in patients with PME and psychiatric disorders or dementia, even when the onset is in late childhood or adolescence.
- MeSH
- dospělí MeSH
- expanze repetic DNA * MeSH
- fenotyp MeSH
- genetická predispozice k nemoci MeSH
- lidé středního věku MeSH
- lidé MeSH
- mozek patologie MeSH
- myoklonické epilepsie progresivní genetika patologie patofyziologie psychologie MeSH
- protein C9orf72 genetika MeSH
- rodina MeSH
- rodokmen MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
... Ethics beyond Guidelines: Culture, Pain, and Conflict David B. Mon \'is -- 5. ... ... McArthur. Michael Polydefkis, Beth B. Murinson, Alan Belzberg, James Campbell. ... ... Descending Modulation after Injury Mary M. Heinricher, Antti Pertovaara, and Michael H. ... ... Stephen Mot ley. Lance McCracken. ... ... Molly A. Sevcik. Nancy M. Luger, and Mary Ann C. Sabino -- 56. ...
Progress in pain research and management ; vol. 24
[1st ed.] xx, 937 s. : il., tab. ; 24 cm
- MeSH
- analgezie MeSH
- bolest diagnóza farmakoterapie MeSH
- výsledek terapie MeSH
- Publikační typ
- kongresy MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- anesteziologie a intenzivní lékařství
... Smith, Jr 1 -- 2 MEDICINE AS A SCIENCE, James B. ... ... INyngaarden 5 -- 3 MEDICINE AS A PUBLIC SERVICE, James B. ... ... Nies 102 -- 27 PAIN AND ITS MANAGEMENT, Kathleen M. Foley and -- Jerome B. ... ... Montgomery Bissell -- 204 ACATALASIA, James B. ... ... Knöchel 2382 -- 542 TRACE METAL POISONING, Donald B. ...
18th edit 2404 s. : obr., tab.,přeruš.bibliogr.
... Contents -- LIST OF ABBREVIATIONS xix -- FOREWORD xxiii -- ADMINISTRATION AND MANAGEMENT -- Skill mix ... ... : killing many birds with one stone -- MG Cheesman, H Tang, and I Marsland -- Data quality, patient classification ... ... Massi-Benedetti, R Mech tier, ? ... ... 785 PS Athwall -- Optical mark reading: evaluation in two medical 787 information systems MJ Bannon, ... ... lessons learned and the action taken -- VJ Peel, M Booth, and J Morgan -- Compositional models of medical ...
First published xxiv, 836 stran : ilustrace, tabulky ; 21 cm
... HUNTER ix -- 1 Physiology of the pneumoperitoneum 757 -- M. P. CALLERY & N. J. ... ... CRIST, M. B. SHAPIRO & T. R. GADACZ -- 3 Endoscopic approaches to oesophageal disease 795 -- B. ... ... B. ... ... McANENA & P. D. WILLSON 5 -- 7 Laparoscopic colonic and rectal resection 867 -- P. M. ... ... M. KRISHNAN -- Index 989 vii ...
Bailliere's clinical gastroenterology ; Vol. 7. Nr. 4
[1st ed.] XI, 757-992 s. : obr., tab., grafy ; 23 cm
- MeSH
- chirurgie trávicího traktu MeSH
- laparoskopie MeSH
- Publikační typ
- sborníky MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- gastroenterologie